BCY-6033

N/A

Report date: 2022/03/21 11:19:10
NME

Base Information

Drug NameBCY-6033
Drug Alias NameBCY-6033
ClassificationOther
Mechanisms of ActionMicrotubule-associated proteins inhibitorsEphrin type-A receptor 2 antagonists
TargetsMicrotubule-associated proteinsEphrin type-A receptor 2
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBicycle Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBicycle Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A